2.125

3.16% 0.065

Alx Oncology Holdings Inc (ALXO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$2.06

Aprire:

$2.08

Volume 24 ore:

780.72K

Relative Volume:

0.55

Capitalizzazione di mercato:

$285.95M

Reddito:

Utile/perdita netta:

$-101.70M

Rapporto P/E:

-1.1207

EPS:

-1.8961

Flusso di cassa netto:

$-84.35M

1 W Prestazione:

+2.66%

1M Prestazione:

+45.55%

6M Prestazione:

+57.41%

1 anno Prestazione:

+327.57%

Intervallo 1D:

$2.00

$2.17

Intervallo di 1 settimana:

$2.00

$2.41

Portata 52W:

$0.444

$2.66

Alx Oncology Holdings Inc Stock (ALXO) Company Profile

Nome

Alx Oncology Holdings Inc

Settore

Healthcare (1096)

Industria

Biotechnology (616)

Telefono

650-466-7125

Indirizzo

323 ALLERTON AVENUE, SOUTH SAN FRANCISCO

Dipendente

Cinguettio

Prossima data di guadagno

2026-08-11

Ultimi documenti SEC

ALXO's Discussions on Twitter

Compare ALXO vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ALXO Alx Oncology Holdings Inc	2.125	285.95M	0	-101.70M	-84.35M	-1.8961
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-19	Iniziato	Wells Fargo	Overweight
2026-03-06	Ripresa	UBS	Buy
2025-11-13	Iniziato	Jefferies	Buy
2025-03-06	Aggiornamento	Jefferies	Hold → Buy
2024-12-19	Downgrade	Jefferies	Buy → Hold
2024-03-08	Downgrade	Stifel	Buy → Hold
2023-12-08	Aggiornamento	Jefferies	Hold → Buy
2021-12-22	Downgrade	Jefferies	Buy → Hold
2021-09-30	Iniziato	Stifel	Buy
2021-05-05	Ripresa	Credit Suisse	Outperform
2021-04-26	Ripresa	Credit Suisse	Outperform
2021-04-06	Iniziato	UBS	Buy
2021-02-10	Iniziato	H.C. Wainwright	Buy
2020-08-11	Iniziato	Cantor Fitzgerald	Overweight
2020-08-11	Iniziato	Credit Suisse	Outperform
2020-08-11	Iniziato	Jefferies	Buy
2020-08-11	Iniziato	Piper Sandler	Overweight

Mostra tutto

Alx Oncology Holdings Inc Borsa (ALXO) Ultime notizie

Jul 09, 2026

BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell? - The Globe and Mail

Jul 09, 2026

Jul 06, 2026

ALX Oncology (ALXO) SVP sells 1,404 shares for RSU tax obligations - Stock Titan

Jul 06, 2026

Jul 05, 2026

ALXOAlx Oncology Holdings Inc Options - Finviz

Jul 05, 2026

Jun 30, 2026

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules - The Manila Times

Jun 30, 2026

Leadership shifts at ALX Oncology (NASDAQ: ALXO) as Garland becomes chair - Stock Titan

Jun 30, 2026

ALX Oncology names Scott Garland chairman, adds general counsel - Investing.com UK

Jun 30, 2026

ALX Oncology names Scott Garland chairman, adds general counsel By Investing.com - Investing.com India

Jun 30, 2026

ALXO Welcomes New Leadership with Board Changes - GuruFocus

Jun 30, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 30, 2026

ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel - Investing News Network

Jun 30, 2026

ALX Oncology appoints Scott Garland as chairman and Michael Listgarten as general counsel to strengthen leadership - Traders Union

Jun 30, 2026

Jun 29, 2026

ALX Oncology Holdings Inc.(NasdaqGS:ALXO) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 29, 2026

ALX Oncology Holdings Inc.(NasdaqGS: ALXO) added to Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026

ALX Oncology Holdings Inc.(NasdaqGS: ALXO) added to Russell 2000 Index - marketscreener.com

Jun 29, 2026